-
Product Insights
NewLikelihood of Approval Analysis for Staphylococcal Infections
Overview How likely is it that the drugs in Staphylococcal Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Staphylococcal Infections Overview A staphylococcal infection or staph infection is an infection...
-
Product Insights
NewLikelihood of Approval Analysis for Bone Disorders
Overview How likely is it that the drugs in Bone Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bone Disorders Overview Bones tend to become weaker or loosen their strength...
-
Product Insights
NewLikelihood of Approval Analysis for Neuropathic Pain (Neuralgia)
Overview How likely is it that the drugs in Neuropathic Pain (Neuralgia) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Neuropathic Pain (Neuralgia) Overview Neuropathic pain, also known as neuralgia, is...
-
Product Insights
NewLikelihood of Approval Analysis for Pleural Effusion
Overview How likely is it that the drugs in Pleural Effusion will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pleural Effusion Overview Pleural Effusion also known as fluid in lungs is...
-
Product Insights
NewLikelihood of Approval Analysis for Papillomaviridae Infections
Overview How likely is it that the drugs in Papillomaviridae Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Papillomaviridae Infections Overview Papillomaviruses are small, non-enveloped, epitheliotropic, double-stranded DNA viruses that...
-
Company Insights
NewMorgan Stanley – Digital Transformation Strategies
Morgan Stanley Digital Transformation Strategies Overview Morgan Stanley is utilizing AI and machine learning to improve its wealth and asset management operations and other operational processes. AI, big data, cloud, and blockchain are among the key technologies under focus for the company. The annual ICT spending of Morgan Stanley was estimated at $4.6 billion in 2023. A major share of this spending is earmarked for acquiring software, ICT services, and network and communications from vendors. Morgan Stanley is utilizing AI...
-
Company Insights
NewElevance Health – Digital Transformation Strategies
Elevance Health Digital Transformation Strategies Overview Elevance Health is tapping the power of big data analytics to analyze data and generate insights, improve member engagement, and detect fraudulent claims. AI, big data, cloud, and automation are among the key technologies under focus for the company. The annual ICT spending of Elevance Health was estimated at $3.8 billion in 2023. A major share of this spending is earmarked for acquiring software, network and communications, and hardware from vendors. Elevance Health Inc...
-
Company Insights
NewDeere & Company – Digital Transformation Strategies
Deere & Company Digital Transformation Strategies Report Overview Deere & Company (John Deere) has been focusing on using artificial intelligence, the Internet of Things (IoT), cloud-based mobile applications, big data, and drones to digitally transform its operations. The annual ICT spending of John Deere was estimated at $3.6 billion for 2023. A major share of this spending is earmarked for acquiring software, hardware, and ICT services from vendors. John Deere is a provider of advanced products and services. It manufactures...
-
Company Insights
NewUBS Group – Digital Transformation Strategies
UBS Group Digital Transformation Strategies Overview UBS uses emerging technologies as a part of its digital transformation strategies. The annual ICT spending of UBS was estimated at $1.1 billion in 2023. A major share of this spending is earmarked for acquiring software, network and communications, and ICT services from vendors. UBS Group (UBS) is a provider of wealth management, banking, asset management, and investment banking solutions. The UBS Personal & Corporate Banking product portfolio consists of financing and investing as...
-
Company Insights
NewBarclays Plc – Digital Transformation Strategies
Barclays Digital Transformation Strategies Overview Barclays has been investing in emerging technologies over the years to improve efficiencies, product offerings, and streamline operations. AI, big data, cloud, and blockchain are among the key technologies under focus for the company. The annual ICT spending of Barclays was estimated at $1.1 billion in 2023. A major share of this spending is earmarked for acquiring software, ICT services, and network and communications from vendors. Barclays Plc (Barclays) is a global financial services provider...